Advertisement
Singapore markets closed
  • Straits Times Index

    3,292.96
    +10.91 (+0.33%)
     
  • S&P 500

    5,116.17
    +16.21 (+0.32%)
     
  • Dow

    38,386.09
    +146.43 (+0.38%)
     
  • Nasdaq

    15,983.08
    +55.18 (+0.35%)
     
  • Bitcoin USD

    62,955.66
    -677.18 (-1.06%)
     
  • CMC Crypto 200

    1,291.07
    -47.99 (-3.59%)
     
  • FTSE 100

    8,174.53
    +27.50 (+0.34%)
     
  • Gold

    2,325.10
    -32.60 (-1.38%)
     
  • Crude Oil

    82.88
    +0.25 (+0.30%)
     
  • 10-Yr Bond

    4.6140
    -0.0550 (-1.18%)
     
  • Nikkei

    38,405.66
    +470.90 (+1.24%)
     
  • Hang Seng

    17,763.03
    +16.12 (+0.09%)
     
  • FTSE Bursa Malaysia

    1,575.97
    -6.69 (-0.42%)
     
  • Jakarta Composite Index

    7,234.20
    +78.41 (+1.10%)
     
  • PSE Index

    6,700.49
    -69.15 (-1.02%)
     

A Look At The Fair Value Of mDR Limited (SGX:Y3D)

Key Insights

  • Using the Dividend Discount Model, mDR fair value estimate is S$0.051

  • mDR's S$0.061 share price indicates it is trading at similar levels as its fair value estimate

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of mDR Limited (SGX:Y3D) as an investment opportunity by projecting its future cash flows and then discounting them to today's value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. It may sound complicated, but actually it is quite simple!

We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.

ADVERTISEMENT

View our latest analysis for mDR

The Model

We have to calculate the value of mDR slightly differently to other stocks because it is a electronic company. In this approach dividends per share (DPS) are used, as free cash flow is difficult to estimate and often not reported by analysts. Unless a company pays out the majority of its FCF as a dividend, this method will typically underestimate the value of the stock. We use the Gordon Growth Model, which assumes dividend will grow into perpetuity at a rate that can be sustained. For a number of reasons a very conservative growth rate is used that cannot exceed that of a company's Gross Domestic Product (GDP). In this case we used the 5-year average of the 10-year government bond yield (2.0%). The expected dividend per share is then discounted to today's value at a cost of equity of 8.5%. Relative to the current share price of S$0.06, the company appears around fair value at the time of writing. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.

Value Per Share = Expected Dividend Per Share / (Discount Rate - Perpetual Growth Rate)

= S$0.005 / (8.5% – 2.0%)

= S$0.05

dcf
dcf

Important Assumptions

We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at mDR as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.5%, which is based on a levered beta of 1.289. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for mDR

Strength

  • Debt is well covered by earnings.

  • Dividend is in the top 25% of dividend payers in the market.

Weakness

  • Current share price is above our estimate of fair value.

Opportunity

  • Has sufficient cash runway for more than 3 years based on current free cash flows.

  • Lack of analyst coverage makes it difficult to determine Y3D's earnings prospects.

Threat

  • Debt is not well covered by operating cash flow.

  • Dividends are not covered by cash flow.

Looking Ahead:

Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For mDR, we've put together three important items you should explore:

  1. Risks: Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with mDR (at least 2 which shouldn't be ignored) , and understanding them should be part of your investment process.

  2. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!

  3. Other Environmentally-Friendly Companies: Concerned about the environment and think consumers will buy eco-friendly products more and more? Browse through our interactive list of companies that are thinking about a greener future to discover some stocks you may not have thought of!

PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the SGX every day. If you want to find the calculation for other stocks just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.